Advanced coronary artery disease (CAD) and ischemic cardiomyopathy with elevated pulmonary artery pressures are criteria of a severe illness. In selected cases surgical revascularization has proved beneficial in terms of survival, reduction of morbidity and lowering the frequency of angina pectoris [6] in numerous studies over the past 25 years. But most of the earlier publications concentrated on patients with angina pectoris (AP) as a dominant symptom. Patients without AP but with predominant signs of congestive heart failure were largely excluded. This has changed recently [l-3,7,8,10,12,16,18] with the advent of the concept of hibernating myocardium. This term is defined as the presence of persistent myocardial and left ventricular dysfunction at rest due to reduced regional coronary blood flow that can be partially or completely restored to normal by myocardial revascularization [5, 19]. Salvage of viable myocardium by successful revascularization improves left ventricular dysfunction. Diagnosis of hibernating myocardium is crucial because it does not leave the patient with chronic heart failure a candidate only for cardiac transplantation.
Patients and methods
We report a consecutive group of patients consisting of 50 males and four females aged between 43 and 72 (mean age 56.7 f 8.5 years). Originally all of the patients were referred from January 1991 to December 1993 to our center as potential candidates for cardiac transplantation.
Thirty-nine (72%) of our patients were suffering from angina pectoris.
Signs of congestive heart failure, especially dyspnea were present in 49 (90%) patients.
There were 86 previous myocardial infarctions in 50 patients. Four patients did not suffer myocardial infarctions (Table 1 ). All patients were screened for general operability and underwent coronary and ventricular angiogram and either had a positron-emission-tomography scan (PET) * Corresponding author.
IOIO-7940/97/$17.00 0 1997 Elsevier Science B.V. All rights reserved. with flow and metabolism tracers or a scintigraphic examination of myocardial metabolism and perfusion. In recent years selected patients also received a stress echocardiography.
The coronary status revealed that 2-vessel-disease was present in three patients, all others had a 3-vessel-disease. Mean cardiac index (through right heart catheterization) was determined with 1.85 _+ 0.26 l/min/m2. Pulmonary artery pressures and pulmonary capillary pressures were elevated ( Table  3) .
All patients had technically operable coronary artery and viable myocardium in those areas potentially perfused by stenosed or occluded coronary arteries. We define viability like most groups as a perfusion/ metabolism mismatch in scintigraphic or PET examinations, i.e. a reduction of perfusion and normal metabolism.
All patients underwent revascularization. Standard extracorporeal circulation was commenced with one aortic and two caval cannulas. Myocardial protection consisted of intermittent aortic crossclamping and mild hypothermia for the performing of the distal anastomoses. The proximal anastomoses were sewn with the aorta partially clamped and the patient rewarmed. We performed 2.4 bypass grafts (range 1-5) per patient always aiming at complete revascularization. The internal thoracic artery was used in 24 patients. Mean ischemic time was 23 min (5-54). In 12 patients transesophageal echocardiography was used intraoperatively to examine contractile function and mitral valve competence. 
Results
To wean the patients from the extracorporeal circulation (ECC) we used dopamine infusion in 33 patients and nitroglycerin infusions in all. Intra-aortic-balloonpumping was used in eight patients, two patients were supported by a left ventricular assist device, one with a biventricular device ( Table 4) .
The post-operative ejection fraction (measured between post-operative day 3 and 10) rose to 40.8%. Three patients died within 30 days. One patient could not be weaned from extracorporeal circulation and died, the second developed multi-organ failure and died on post-operative day 6 and the third one died after referral to another hospital from acute cardiac failure on post-operative day 22. Non-lethal complications included three episodes of pneumonia and six episodes of transient renal dysfunction. Sixteen patients needed ventilatory support longer than 6 h.
During follow up time (mean 34.8 months) three patients died from cardiac causes. Six patients were transplanted and four others await transplantation. Twenty-nine of the 38 remaining patients are in NYHA class II and nine are in class III (Table 5) .
Eleven patients underwent cardiac catheterization 3-6 months after the operation. Four of 27 bypass grafts were found occluded. In eight patients LVEF was significantly improved, in three patients overall ventricular performance was identical to preoperative findings. In all previously hypokinetic or akinetic segments with patent bypass grafts regional wall motion was improved together with global left ventricular function, with reduction of filling pressures and end-diastolic and endsystolic volumes. 
Discussion
Cardiologists and cardiac surgeons are confronted with a multitude of problems in patients suffering from ischemic cardiomyopathy.
This condition is a poorly defined entity [5, 14, 17] . We use this term for a group of patients, who suffer from endstage coronary artery disease and left ventricular dysfunction. Therapeutic options are heart transplantation on one side and surgical revascularization of the hibernating myocardium on the other [7, 16, 18] ). Ideally a patient with features of chronic heart failure and advanced coronary artery disease should undergo a diagnostic procedure which clarifies the presence or absence of viable myocardium and graftable coronary arteries. If both conditions are met, the patient is a candidate for revascularization [3, 10, 12, 18 ]. If not HTX should be proposed. All patients in our group displayed severely reduced left ventricular performance with a low LVEF, elevated end-diastolic and pulmonary artery pressures and a large percentage (68.5) suffered from some degree of ischemic mitral regurgitation. The cardiac index was uniformly reduced.
Hemodynamic parameters alone, even when the whole array of modern tools is used, provide only information on the preoperative status. There is no single parameter or a combination of hemodynamic parameters predicting success or failure of surgical revascularization. What if we add positron emission tomography, the current gold standard for detecting viable myocardium to or diagnostic armamentarium? Only the endpoints are clearly defined: scar tissue without metabolism and normal myocardium with a normal perfusion/metabolism ratio. In studies by Bonow et al. [4] PET is able to accurately differentiate viable myocardium from fibrosis (scarred tissue) with the positive predictive value ranging from 75 to 80% and the negative predictive value from 78 to 92%. The definition of the viability of myocardial areas is far from easy because vital myocardium, scar tissue and viable but hibernating areas are mixed in a three dimensional organ [12, 14, 17, 20] .
In a paper by Alfieri et al. [3] rest distribution of Thallium-201 identified viability which was not necessarily associated with the early recovery of function post-operatively. When the echo-dobutamine test was found positive, the recovery of function usually occurred immediately after revascularization and the operative risk was low even in the presence of severely compromised left ventricular function. Cigarroa et al. [9] studied 49 patients with dobutamine-stress echocardiography (DSE). Contractile reserve during DSE was defined by the presence of two criteria: (1) improved systolic wall thickening in at least two adjacent abnormal segments and (2) 2 20% improvement in regional wall thickening score. The presence or absence of contractile reserve on preoperative DSE predicted recovery of ventricular function in the 25 patients who underwent successful revascularization. Thus, nine of 11 patients with contractile reserve had improved systolic wall thickening after revascularization (hibernating myocardium), whereas 12 of 14 patients without contractile reserve did not improve. Future developments will include the echocardiographic diagnosis of tissue structure and assessment of microvasculature integrity [9, 11, 15] . Another issue is the interval between revascularization and improvement of ventricular function. While some patients show an early post-operative improvement, in others it might take several months [13] .
As more coronary revascularizations are performed either surgically or interventionally the percentage of patients with redo procedures is likely to rise, even more so in the group of patients with severely impaired left ventricular function. If coronary arteries are still graftable, a redo procedure, in our opinion, is no contraindication. Still a percentage (20-30%) of areas of hibernating myocardium does not show improvement in regional wall motion after apparently successful revascularization.The answer to this is probably hidden in the molecular structure of the myocardium or in the microvasculature. Furthermore remote myocardial dysfunction leading to elevated wall tension in an enlarged ventricle influences the capillary flow in an area of hibernating myocardium, which in turn compromises the run off in the grafted coronary vessels. Furthermore the success of coronary revascularization is dependent on a complex interaction between compensatory mechanisms, coronary anatomy and patient selection [4, 9, [11] [12] [13] [14] 201 .
Standardized surgical and perfusion techniques will only allow for marginal improvements in the future. The future improvements will result from even more refined diagnostic tools.
Another problem today is the severe shortage of donor organs. Every effort should be made to save valuable organs for those patients, who need them most urgently. One way is to revascularize those patients with CAD and ischemic cardiomyopathy who do benefit at least for some years. If left ventricular function deteriorates again following revascularization those patients can still be successfully transplanted. We regard technically operable coronary arteries a prerequisite for the restoration of blood flow. Reasonably large subepicardial vessels are one condition to be met, the microvasculature's function can be assessed with DSE and finally the myocardium viability by means of PET. Perhaps in the future these parameters, combined with hemodynamic data, will allow an exact prediction of myocardial performance following revascularization. Because today even advanced preoperative diagnostic tools such as PET scan and stress echocardiography do not entirely preclude perioperative myocardial failure in all patients with evidence of hibernating myocardium and ischemic cardiomyopathy. In these cases ventricular assist devices have been an effective means to either support the patient's circulation temporarily or as a bridge to transplantation. Of the three patients in this series one died from multiple organ failure, one could be successfully weaned from the assist device and the third one was subsequently transplanted and is well today. We are encouraged by these results to continue in this direction in this highly selected group of patients.
